EW
40
-4
APH
65
-2
AAP
26
2
GS
70
2
MS
62
5
CME
37
3
MCHP
54
4
MET
58
-2
MNST
61
-2
PG
51
-5
NFLX
61
-3
DOW
54
2
GIS
43
2
CTAS
59
-5
ICE
63
-3
BBY
51
2
URBN
50
-12
AME
48
-12
ACN
42
2
DD
52
3
EW
40
-4
APH
65
-2
AAP
26
2
GS
70
2
MS
62
5
CME
37
3
MCHP
54
4
MET
58
-2
MNST
61
-2
PG
51
-5
NFLX
61
-3
DOW
54
2
GIS
43
2
CTAS
59
-5
ICE
63
-3
BBY
51
2
URBN
50
-12
AME
48
-12
ACN
42
2
DD
52
3
Financhill
Back

China SXT Pharmaceuticals 10K Form

Buy
58

SXTC
China SXT Pharmaceuticals

Last Price:
1.09
Seasonality Move:
-43.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SXTC News And Ratings

See the #1 stock for the next 7 days that we like better than SXTC

SXTC Financial Statistics

Sales & Book Value

Annual Sales: $1.97M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $6.97
Price / Book: 0.12

Profitability

EPS (TTM): -29.04810
Net Income (TTM): $-14.14M
Gross Margin: $426.27K
Return on Equity: -122.37%
Return on Assets: -63.94%

China SXT Pharmaceuticals Earnings Forecast

Key China SXT Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 7 years for SXTC is 21.62%.
  • The Selling, General & Administrative Expenses for SXTC have been equal to 306.02% of Gross Profit Margin.
  • The Net Earning history of SXTC is -301.00% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

China SXT Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SXTC
CUSIP: G2161P
Website: sxtchina.com

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 1.47
Quick Ratio: 1.4

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SXTC Technical Analysis vs Fundamental Analysis

Buy
58
China SXT Pharmaceuticals (SXTC) is a Buy

Is China SXT Pharmaceuticals a Buy or a Sell?